FindTrial
Sign In

Study on the Application Value of Dexmedetomidine Combined with Sufentanil Anesthesia in Microballoon Compression of the Trigeminal Ganglio

Study on the Application Value of Dexmedetomidine Combined with Sufentanil Anesthesia in Microballoon Compression of the Trigeminal Ganglio

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098737
Enrollment
Unknown
Registered
2025-03-13
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trigeminal neuralgia

Interventions

Experimental group:Intravenous administration of dexmedetomidine combined with sufentanil

Sponsors

Department of Pain, First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1: Patients meeting the diagnostic criteria for primary trigeminal neuralgia 2: Patients with ineffective oral medication or intolerable side effects 3: Aged 40–85 years 4: ASA class I–II

Exclusion criteria

Exclusion criteria: 1: Patients unable to cooperate with the procedure 2: Patients with secondary trigeminal neuralgia 3: Patients with severe dysfunction of major organs (e.g., cardiac, hepatic, renal) 4: Patients allergic to analgesic medications 5: ASA class >III

Design outcomes

Primary

MeasureTime frame
Facespainscale-Revised, FPS-R;—

Secondary

MeasureTime frame
Modified Observer's Assessment of Alertness/Sedation Scale, MOAA/S;Heart rate;Blood pressure;Blood oxygen saturation;—

Countries

China

Contacts

Public ContactWei Jun

The First Affiliated Hospital of Gannan Medical University

weijun5812@163.com+86 139 0707 5812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026